Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01408823 · ClinicalTrials.gov registry record
Pharmacokinetics of Aminocaproic Acid in Scoliosis Surgery
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 20
- Enrollment target
NCT01408823 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 20 participants.
The verdict
NCT01408823 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study will evaluate the pharmacokinetics of antifibrinolytic drug epsilon-aminocaproic acid (EACA) in children undergoing Posterior spinal fusion surgery (PSF) at The Children's Hospital of Philadelphia (CHOP) who receive EACA at the standard dose reported in the literature for this population and currently in use at CHOP.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-07 |
| Est. Completion | 2011-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01408823
The ClinicalTrials.gov registry entry for NCT01408823 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01408823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01408823 about?
NCT01408823 is a clinical study titled "Pharmacokinetics of Aminocaproic Acid in Scoliosis Surgery". This study will evaluate the pharmacokinetics of antifibrinolytic drug epsilon-aminocaproic acid (EACA) in children undergoing Posterior spinal fusion surgery (PSF) at The Children's Hospital of Philadelphia (CHOP) who receive EACA at the standard dose reported in the literature for this population ...
What is the current status of trial NCT01408823?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-07. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT01408823?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.